How Convertible Debt Deal Further Strengthened Safeguard’s Balance Sheet
Safeguard’s convertible debt deal last November reduced Safeguard’s debt to less than a third of its debt level in 2005 and cut interest rate expenses…
Posted by
Safeguard’s convertible debt deal last November reduced Safeguard’s debt to less than a third of its debt level in 2005 and cut interest rate expenses…
Posted by
In 2002, in the wake of the dot-com era and a number of major corporate and accounting scandals, the Sarbanes-Oxley Act was passed. The federal…
Posted by
Much has been written recently about the amount of cash companies are accumulating through their operations. In an August 2011 report, the Wall Street Journal…
Posted by
While developing a perspective on future trends is always a tricky business, there are few moments when the direction of things seems obvious, such as…
Posted by
Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…
Posted by
Here at Safeguard Scientifics, we provide capital to growth-stage companies in both the life sciences and technology. It’s important to note, however, that Safeguard provides…
Posted by
Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…
Posted by
Safeguard Scientifics announced today that it has signed a definitive agreement to acquire a 36% ownership interest in Penn Mezzanine, a mezzanine platform which commenced operations…
Posted by
We are only beginning to realize the true impact of a robust social presence in the field of Investor Relations. Even as more and more…
Posted by